| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02767024 Details | 2018-10-31 Interventional | 4 | 0 | Dobutamine Furosemide Nitroprusside Heart Failure Acute Heart Fai… | No patients enrolled - | |||
| NCT01956604 2013-000815-26 2013-000815-26 Details | 2018-10-31 Interventional | 2 | 20 | Clonidine Delirium | The inclusion rate was too low, due to the exclusion criteria. - | |||
| NCT00963547 Details | 2018-10-31 Interventional | 1 | [1 Refs] | 33 | Lapatinib Trastuzumab Neoplasms Advanced Solid … Breast Cancer | - - | ||
| NCT00043810 Details | 2018-10-31 Interventional | 1/2 | 3 | Busulfan Fludarabine Fludarabine pho… GEL protein, Ge… Leukemia, Myelo… Leukemia, Myelo… Myelodysplastic… Acute Myelogeno… Myelodysplastic… | - - | |||
| NCT00041782 Details | 2018-10-31 Interventional | 2 | 26 | Dalteparin Heparin, Low-Mo… Tinzaparin Thrombosis Venous Thrombos… Deep Vein Throm… Neoplasms | - - | |||
| NCT00038805 Details | 2018-10-31 Interventional | 2/3 | 3 | Gemtuzumab Leukemia Myelodysplastic… Precursor Cell … Preleukemia | - - | |||
| NCT02410551 Details | 2018-10-30 Interventional | 2 | 4 | Busulfan Fludarabine Fludarabine pho… Myeloproliferat… Neoplasms Myeloproliferat… | - - | |||
| NCT01655823 Details | 2018-10-30 Interventional | 2 | 125 | Tetrodotoxin Neuralgia Peripheral Nerv… Neuropathic Pai… Pain Peripheral Neur… | Interim analysis completed and decided to terminate and proceed to Phase 3 trial. - | |||
| NCT00429169 Details | 2018-10-30 Interventional | 4 | [1 Refs] | 101 | Bupropion Paroxetine Depression Depressive Diso… Suicide | Interim analysis showed differential treatment effects. Significant dropout meant the number of subjects with analyzable data was smaller than the number enrolled. An interim analysis of this pilot study showed differential treatment effects so a decision was made to stop enrollment early. | ||
| NCT01817257 2012-004117-14 Details | 2018-10-29 Interventional | 2 | [1 Refs] | 2 | Dalteparin Enoxaparin Heparin Heparin, Low-Mo… Tinzaparin Embolism Pulmonary Embol… Thromboembolism Thrombosis Venous Thromboe… Venous Thrombos… Cancer Deep Vein Throm… Pulmonary Embol… | Early findings showed trial was not feasible - | ||
| NCT01347866 2011-001671-39 Details | 2018-10-29 Interventional | 1 | 105 | Gedatolisib Irinotecan Neoplasms Advanced Cancer | Refer to Detailed Description for documentaion of Termination Statement. This study was terminated prematurely for strategic reasons based on an internal portfolio prioritization. | |||
| NCT03431272 Details | 2018-10-25 Interventional | 4 | 0 | Lifitegrast Dry Eye Syndrom… Eye Diseases Keratoconjuncti… Contact Lens Dr… | no longer interest / resources to start study - | |||
| NCT03414450 Details | 2018-10-25 Interventional | 1 | 0 | Dasatinib Blast Crisis Leukemia Leukemia, Lymph… Leukemia, Myelo… Leukemia, Myelo… Precursor Cell … Chronic Myeloid… Chronic Myeloid… Ph+ Acute Lymph… Ph- Acute Lymph… | Withdrawal requested by D3 - | |||
| NCT02266797 Details | 2018-10-25 Interventional | 3 | 4 | Dexamethasone Deglutition Dis… Dysphagia After… | - - | |||
| NCT01606800 Details | 2018-10-25 Interventional | 4 | 45 | Interferon alph… Peginterferon a… Ribavirin Hepatitis Hepatitis A Hepatitis C Hepatitis C, Ch… | The trial was terminated due to change in new standard of therapy during the study period. This Trial was prematurely terminated due to the availability of more promising treatment for HCV participants and the change in treatment guidelines, which will offer the patient a better treatment opportunity. | |||
| NCT00796510 Details | 2018-10-25 Interventional | 3 | 3 | Sildenafil Citr… Sitaxsentan Familial Primar… Hypertension Hypertension, P… Pulmonary Arter… Pulmonary Hyper… | Safety Issue: The trial was prematurely terminated on Dec 9, 2010, due to safety concerns,
specifically new emerging evidence of hepatic injury Due to the premature termination only 3 participants were recruited into this study. No summarization or analysis was done. | |||
| NCT00254436 Details | 2018-10-25 Interventional | 3 | 50 | Epoetin Alfa Gastrointestina… Rectal Neoplasm… Gastrointestina… Rectal Cancer | - - | |||
| NCT01821040 2011-002353-57 Details | 2018-10-24 Interventional | 3 | 62 | Prednisone Giant Cell Arte… Polymyalgia Rhe… | - - | |||
| NCT01777854 Details | 2018-10-24 Interventional | 4 | 6 | Omeprazole Gastroesophagea… Laryngopharynge… Throat Pain | Lack of patient interest in the study. - | |||
| NCT00947466 2008-002428-27 Details | 2018-10-24 Interventional | 1/2 | 25 | Buprenorphine Mucositis Chemotherapy In… Mouth Pain | 25 patients have been recruited and it was considered that further recruitment would add no
extra PK information - |